Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparibResearch in context

Authors: Xiaonan Zhang, Natallia Rameika, Lei Zhong, Verónica Rendo, Margus Veanes, Snehangshu Kundu, Sandro Nuciforo, Jordan Dupuis, Muhammad Al Azhar, Ioanna Tsiara, Pauline Seeburger, Shahed Al Nassralla, Viktor Ljungström, Richard Svensson, Ivaylo Stoimenov, Per Artursson, Markus H. Heim, Daniel Globisch, Tobias Sjöblom

Source: EBioMedicine, Vol 109, Iss , Pp 105368- (2024)

Subject Terms: Loss of heterozygosity, Loss of function, Hepatocellular carcinomas, CYP2D6 and talazoparib, Medicine, Medicine (General), R5-920

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352396424004043; https://doaj.org/toc/2352-3964

Access URL: https://doaj.org/article/c93831231c574e67b595b2f52334f442